THE EXPRESSION OF THE INTERLEUKIN-6 GENE IS INDUCED BY THE HUMAN-IMMUNODEFICIENCY-VIRUS-1 TAT PROTEIN

被引:234
作者
SCALA, G [1 ]
RUOCCO, MR [1 ]
AMBROSINO, C [1 ]
MALLARDO, M [1 ]
GIORDANO, V [1 ]
BALDASSARRE, F [1 ]
DRAGONETTI, E [1 ]
QUINTO, I [1 ]
VENUTA, S [1 ]
机构
[1] UNIV REGGIO CALABRIA, SCH MED, DEPT CLIN & EXPTL MED, I-88100 CATANZARO, ITALY
关键词
D O I
10.1084/jem.179.3.961
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Human immunodeficiency virus 1 (HIV1) infection is associated with severe psoriasis, B cell lymphoma, and Kaposi's sarcoma. A deregulated production of interleukin 6 (IL-6) has been implicated in the pathogenesis of these diseases. The molecular mechanisms underlying the abnormal IL-6 secretion of HIV1-infected cells may include transactivation of the IL-6 gene by HIV1. To test this hypothesis, we used the pIL6Pr-chloramphenicol acetyltransferase (CAT) plasmid, an IL-6 promoter-CAT construct, as a target of the transactivating function of the HIV1 TAT protein. By cotransfecting the pIL6Pr-CAT and the tat-expressing pSVT8 plasmid in MC3 B-lymphoblastoid or in HeLa epithelial cells, we observed that TAT transactivates the human IL-6 promoter. These results were confirmed when pIL6Pr-CAT was transfected in MC3 or HeLa cells that constitutively expressed the tar gene in a sense (pSVT8 cells) or antisense (pSVT10 cells) orientation. 5' deletion plasmids of pIL6Pr-CAT, in which regions at -658, -287, and -172 were inserted 5' to the cat gene, were transiently transfected in pSVT10 and pSVT8 cells and showed that TAT-induced activation of the IL-6 promoter required a minimal region located between -287 and -54 bp. Moreover, experiments with plasmids carrying the -658, -287, and -172 bp regions of the IL-6 promoter inserted downstream to a TAR-deleted HIV1-LTR identified the sequence of -172 to -54 as the minimal region of the IL-6 promoter required for TAT to transactivate the TAR-deleted HIV1-LTR. By DNA-protein binding experiments, tat-transfected cells expressed a consistent increase in kappa B and nuclear factor (NF)-IL-6 binding activity. Accordingly, the pDRCAT and IL-1REK9CAT, carrying tandem repeats of NF-kappa B or NF-IL6 binding motifs, respectively, were activated in TAT-expressing cells. The biological relevance of the TAT-induced IL-6 secretion was addressed by generating 7TD1 cells, an IL-6-dependent mouse cell line, stably expressing the tat gene. These tat-positive cells expressed the endogenous IL-6 gene, secreted high amounts of murine IL-6, and grew efficiently in the absence of exogenous IL-6. Moreover, the tat-positive 7TD1 cells sustained the growth of parental 7TD1 cells and showed a dramatic increase in their tumorigenic potency. These results suggest that TAT protein may play a role in the pathogenesis of some HIV1-associated diseases by modulating the expression of host cellular genes.
引用
收藏
页码:961 / 971
页数:11
相关论文
共 45 条
[1]   A NUCLEAR FACTOR FOR IL-6 EXPRESSION (NF-IL6) IS A MEMBER OF A C/EBP FAMILY [J].
AKIRA, S ;
ISSHIKI, H ;
SUGITA, T ;
TANABE, O ;
KINOSHITA, S ;
NISHIO, Y ;
NAKAJIMA, T ;
HIRANO, T ;
KISHIMOTO, T .
EMBO JOURNAL, 1990, 9 (06) :1897-1906
[2]   TAR-INDEPENDENT ACTIVATION OF THE HIV-1-LTR - EVIDENCE THAT TAT REQUIRES SPECIFIC REGIONS OF THE PROMOTER [J].
BERKHOUT, B ;
GATIGNOL, A ;
RABSON, AB ;
JEANG, KT .
CELL, 1990, 62 (04) :757-767
[3]  
BREEN EC, 1990, J IMMUNOL, V144, P480
[4]  
BROWN TJ, 1991, J IMMUNOL, V147, P2175
[5]   EFFECTS OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TAT PROTEIN ON THE EXPRESSION OF INFLAMMATORY CYTOKINES [J].
BUONAGURO, L ;
BARILLARI, G ;
CHANG, HK ;
BOHAN, CA ;
KAO, V ;
MORGAN, R ;
GALLO, RC ;
ENSOLI, B .
JOURNAL OF VIROLOGY, 1992, 66 (12) :7159-7167
[6]  
CAPUTO A, 1990, J ACQ IMMUN DEF SYND, V3, P372
[7]  
CLOUSE KA, 1991, J IMMUNOL, V147, P2892
[8]   DIFFERENCES AMONG HUMAN IMMUNODEFICIENCY VIRUS-STRAINS IN THEIR CAPACITIES TO INDUCE CYTOLYSIS OR PERSISTENT INFECTION OF A LYMPHOBLASTOID CELL-LINE IMMORTALIZED BY EPSTEIN-BARR-VIRUS [J].
DAHL, K ;
MARTIN, K ;
MILLER, G .
JOURNAL OF VIROLOGY, 1987, 61 (05) :1602-1608
[9]   ISOLATION OF A CELLULAR PROTEIN THAT BINDS TO THE HUMAN-IMMUNODEFICIENCY-VIRUS TAT PROTEIN AND CAN POTENTIATE TRANSACTIVATION OF THE VIRAL PROMOTER [J].
DESAI, K ;
LOEWENSTEIN, PM ;
GREEN, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (20) :8875-8879
[10]   ACQUIRED IMMUNODEFICIENCY SYNDROME - EPIDEMIOLOGIC, CLINICAL, IMMUNOLOGICAL, AND THERAPEUTIC CONSIDERATIONS [J].
FAUCI, AS ;
MACHER, AM ;
LONGO, DL ;
LANE, HC ;
ROOK, AH ;
MASUR, H ;
GELMANN, EP .
ANNALS OF INTERNAL MEDICINE, 1984, 100 (01) :92-106